Cardiology

CABG may be best method to revascularize in diabetes

(HealthDay)—In patients with diabetes and multivessel coronary artery disease (MV-CAD), coronary artery bypass grafting (CABG) may be the preferred method of revascularization, with lower rates of major adverse cardiac ...

Cardiology

Type 2 myocardial infarction definition impacts prognosis

(HealthDay)—Definition of type 2 myocardial infarction (T2MI) using a method that does not require the presence of coronary artery disease is associated with a lower event-related mortality rate, according to a study published ...

Cardiology

No lasting benefit for follow-up coronary angiography after PCI

(HealthDay)—For patients who have undergone percutaneous coronary intervention (PCI), routine follow-up coronary angiography (FUCAG) has no long-term clinical benefit, according to a study published online Jan. 1 in JACC: ...

Cardiology

Less efficacy than expected in largest drug-eluting stent trial

Rome, Italy 30 August 2016: New generation drug eluting stents (new DES) did not outshine contemporary bare metal stents (BMS) as they were expected to, in a surprise finding of the largest randomized stent trial to date.

Cardiology

Mortality up with no revascularization in STEMI

(HealthDay)—Mortality is increased for patients with non-ST-segment elevation myocardial infarction (NSTEMI) who do not undergo coronary revascularization, according to a study published in the July 1 issue of The American ...

Cardiology

Review finds CABG bests PCI in end-stage renal disease

(HealthDay)—For patients with end-stage renal disease (ESRD) referred for coronary revascularization, coronary artery bypass grafting (CABG) is associated with a small decrease in long-term mortality compared with percutaneous ...

page 2 from 8